In conclusion, the add-on of GLP-1 analogue to the intensive insulin therapy with CSII not only significantly showed further effect among glucose control but remarkably potentiated the β- cell function in patients with poorly controlled type 2 diabetes mellitus. Here, INS is linked to type 2 diabetes mellitus.